Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera RHWM, Derksen RH, de Groot PG, Koike T, Meroni PL, Reber G. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295–306.

Article  CAS  PubMed  Google Scholar 

Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss. Fertil Steril. 2013;90:S60.

Google Scholar 

Schreiber K, Sciascia S, de Groot PG, Devreese K, Jacobsen S, Ruiz-Irastorza G, Salmon JE, Shoenfeld Y, Shovman O, Hunt BJ. Antiphospholipid syndrome. Nat Rev Dis Primers. 2018;4:17103.

Article  PubMed  Google Scholar 

Rodrigues V, Soligo AD, Pannain GD. Antiphospholipid antibody syndrome and infertility. Rev Bras Ginecol. 2019;41:621–7.

Article  Google Scholar 

Rai RS, Clifford K, Cohen H, Regan LJHR. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod. 1995;10(12):3301–4.

Article  CAS  PubMed  Google Scholar 

Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, Sáez-Comet L, Lefkou E, Mekinian A, Belizna C, Ruffatti A, Tincani A, Marozio L, Espinosa G, Cervera R, Ríos-Garcés R, De Carolis S, Latino O, LL E, Chighizola CB, Gerosa M, Pengo V, et al. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a survey of 1000 consecutive cases. Autoimmun Rev. 2019;18:406–14.

Article  PubMed  Google Scholar 

Barinotti A, Radin M, Cecchi I, Foddai S, Rubini E, Roccatello D, Sciascia S, Menegatti E. Genetic factors in antiphospholipid syndrome: preliminary experience with whole exome sequencing. Int J Mol Sci. 2020;21(24):9551.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bilal M, Katara G, Dambaeva S, Kwak-Kim J, Gilman‐Sachs A, Beaman KD. Clinical molecular genetics evaluation in women with reproductive failures. 2021;85(4):e13313.

Yin H, Borghi MO, Delgado-Vega AM, Tincani A, Meroni PL, Alarcon-Riquelme ME. Association of STAT4 and BLK, but not BANK1 or IRF5, with primary antiphospholipid syndrome. Arthritis Rheum. 2009;60:2468–71.

Article  CAS  PubMed  Google Scholar 

Horita T, Atsumi T, Yoshida N, Nakagawa H, Kataoka H, Yasuda S, Koike T. STAT4 single nucleotide polymorphism, rs7574865 G/T, as a risk for antiphospholipid syndrome. Ann Rheum Dis. 2009;68:1366–7.

Article  CAS  PubMed  Google Scholar 

Sugiura-Ogasawara M, Omae Y, Kawashima M, Toyo-Oka L, Khor S, Sawai H, Horita T, Atsumi T, Murashima A, Fujita D, Fujita T, Morimoto S, Morishita E, Katsuragi S, Kitaori T, Katano K, Ozaki Y, Tokunaga KJ. The first genome-wide association study identifying new susceptibility loci for obstetric antiphospholipid syndrome. J Hum Genet. 2017;62:831–8.

Article  CAS  PubMed  Google Scholar 

Ochoa E, Iriondo M, Bielsa A, Ruiz-Irastorza G, Estonba A, Zubiaga AM. Thrombotic antiphospholipid syndrome shows strong haplotypic association with SH2B3-ATXN2 locus. PLoS One. 2013;8:e67897.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prieto GA, Cabral AR, Zapata-Zuniga M, Simon AJ, Villa AR, Alarcon-Segovia D, Cabiedes J. Valine/valine genotype at position 247 of the beta2-glycoprotein I gene in Mexican patients with primary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies. Arthritis Rheum. 2003;48:471–4.

Article  CAS  PubMed  Google Scholar 

Muller-Calleja N, Rossmann H, Muller C, Wild P, Blankenberg S, Pfeiffer N, Binder H, Beutel ME, Manukyan D, Zeller T, Lackner KJ. Antiphospholipid antibodies in a large population-based cohort: genome-wide associations and effects on monocyte gene expression. Thromb Haemost. 2016;116:115–23.

Article  PubMed  Google Scholar 

Athanasiadis G, Sabater-Lleal M, Buil A, Souto JC, Borrell M, Lathrop M, Watkins H, Almasy L, Hamsten A, Soria JM. Genetic determinants of plasma β2-glycoproteinI levels: a genome-wide association study in extended pedigrees from Spain. J Thromb Haemost. 2013;11:521–8.

Article  CAS  PubMed  Google Scholar 

Kolialexi A, Tsangaris G, Sifakis S, Gourgiotis D, Katsafadou A, Lykoudi A, Marmarinos A, Mavreli D, Pergialiotis V, Fexi D, Mavrou A, Papaioanou G, Papantoniou NJ. Plasma biomarkers for the identification of women at risk for early-onset preeclampsia. Expert Rev Proteom. 2017;14:269–76.

Article  CAS  Google Scholar 

Provost P, Tremblay YJ. Elevated expression of four apolipoprotein genes during the 32-35 week gestation window in the human developing lung. Early Hum Dev. 2010;86:529–34.

Article  CAS  PubMed  Google Scholar 

Kopylov A, Papysheva O, Gribova I, Kotaysch G, Kharitonova L, Mayatskaya T, Sokerina E, Kaysheva A, Morozov SJ. Molecular pathophysiology of diabetes mellitus during pregnancy with antenatal complications. Sci Rep. 2020;10:19641.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao J, Ma J, Deng Y, Kelly J, Kim K, Bang S, Lee H, Li Q, Wakeland E, Qiu R, Liu M, Guo J, Li Z, Tan W, Rasmussen A, Lessard C, Sivils K, Hahn B, Grossman J, et al. A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases. Nat Genet. 2017;49:433–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Olsson L, Johansson Å, Gullstrand B, Jönsen A, Saevarsdottir S, Rönnblom L, Leonard D, Wetterö J, Sjöwall C, Svenungsson E, Gunnarsson I, Bengtsson A, Holmdahl RJ. NCF1A single nucleotide polymorphism in the gene leading to reduced oxidative burst is associated with systemic lupus erythematosus. Ann Rheum Dis. 2017;76:1607–13.

Article  CAS  PubMed  Google Scholar 

Hultqvist M, Olofsson P, Holmberg J, Bäckström B, Tordsson J, Holmdahl R. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc Natl Acad Sci USA. 2004;101:12646–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kelkka T, Kienhöfer D, Hoffmann M, Linja M, Wing K, Sareila O, Hultqvist M, Laajala E, Chen Z, Vasconcelos J, Neves E, Guedes M, Marques L, Krönke G, Helminen M, Kainulainen L, Olofsson P, Jalkanen S, Lahesmaa R, et al. Reactive oxygen species deficiency induces autoimmunity with type 1 interferon signature. Antioxid Redox Signal. 2014;21:2231–45.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Olsson LM, Johansson ÅC, Gullstrand B, Jönsen A, Saevarsdottir S, Rönnblom L, Leonard D, Wetterö J, Sjöwall C, Svenungsson EJ. A single nucleotide polymorphism in the NCF1 gene leading to reduced oxidative burst is associated with systemic lupus erythematosus. Ann Rheum Dis. 2017;76(9):1607–13.

Article  CAS  PubMed  Google Scholar 

Linge P, Arve S, Olsson LM, Leonard D, Sjöwall C, Frodlund M, Gunnarsson I, Svenungsson E, Tydén H, Jönsen A, Kahn R, Johansson Å, Rönnblom L, Holmdahl R, Bengtsson A. NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus. Ann Rheum Dis. 2020;79:254–61.

Article  CAS  PubMed  Google Scholar 

De Boer M, Gavrieli R, van Leeuwen K, Wolf H, Dushnitzki M, Bar-Yosef Y, Bar-Ziv A, Behar D, Lipitz S, Miller T, Tool A, Kuijpers T, van den Berg T, Wolach B, Roos D, Pras E. A false-carrier state for the c.579G>A mutation in the NCF1 gene in Ashkenazi Jews. J Med Genet. 2018;55:166–72.

Article  PubMed  Google Scholar 

Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005;15:97–8.

Article  CAS  PubMed  Google Scholar 

Pozzi N, Acquasaliente L, Frasson R, Cristiani A, Moro S, Banzato A, Pengo V, Scaglione G, Arcovito A, De Cristofaro R, De Filippis V. β2 -Glycoprotein I binds to thrombin and selectively inhibits the enzyme procoagulant functions. J Thromb Haemost. 2013;11:1093–102.

Article  CAS  PubMed  Google Scholar 

Athanasiadis G, Sabater-Lleal M, Buil A, Souto J, Borrell M, Lathrop M, Watkins H, Almasy L, Hamsten A, Soria JM. Genetic determinants of plasma β2-glycoprotein I levels: a genome-wide association study in extended pedigrees from Spain. J Thromb Haemost. 2013;11:521–8.

Article  CAS  PubMed  Google Scholar 

Miyakis S, Giannakopoulos B, Krilis S. Beta 2 glycoprotein I--function in health and disease. Thromb Res. 2004;114:335–46.

Article  CAS  PubMed  Google Scholar 

Tan Y, Bian Y, Song Y, Zhang Q, Wan X. Exosome-contained APOH associated with antiphospholipid syndrome. Front Immunol. 2021;12:604222.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang L, Zeng W, Lu X, Wang Q, Liu H, Cheng Z, Wu Y, Hu B, Jian X, Guo T, Wang H, Hu Y. Identification of APOH polymorphisms as common genetic risk factors for venous thrombosis in the Chinese population. J Thromb Haemost. 2014;12:1616–25.

Article  CAS  PubMed  Google Scholar 

Guo T, Yin RX, Li H, Wang YM, Wu JZ, Yang DZ. Association of the Trp316Ser variant (rs1801690) near the apolipoprotein H (β2 glycoprotein-I) gene and serum lipid levels. Int J Clin Exp Pathol. 2015;8(6):7291.

PubMed  PubMed Central  Google Scholar 

Ruano G, Bernene J, Windemuth A, Bower B, Wencker D, Seip RL, Kocherla M, Holford TR, Petit WA, Hanks S. Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazone. Clin Chim Acta. 2009;400:48–55.

Article  CAS  PubMed  Google Scholar 

Hasstedt SJ, Coon H, Xin Y, Adams TD, Hunt SC. APOH interacts with FTO to predispose to healthy thinness. Hum Genet. 2016;135:201–7.

Article  PubMed